Private Trust Company’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Private Trust Company’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-77	Closed	-$9.32K	–	2391
2023 Q1	$9.32K	Buy	77 +56	+267%	+$6.44K	﹤0.01%	1607
2022 Q4	$2K	Hold	21	–	–	﹤0.01%	2062
2022 Q3	$2K	Buy	+21	New	+$2.22K	﹤0.01%	1922

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Private Trust Company's BSX.PRA Position: Q2 2023 in Review

Private Trust Company sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 77 shares — an estimated $9.32K sold.

Private Trust Company first reported a position in BSX.PRA in Q3 2022 and held it in 3 quarters. The position peaked at $9.32K in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Private Trust Company reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Private Trust Company sold 77 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $9.32K.
Private Trust Company first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2022 and held it in 3 quarters.
Private Trust Company's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $9.32K in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Private Trust Company's 13F filing for Q2 2023, filed 28 Jul 2023.